FDA Releases Two Discussion Papers to Spur Conversation about Artificial Intelligence and Machine Learning in Drug Development and Manufacturing
AI/ML can help bring safe, effective, and high-quality treatments to patients faster. This post highlights the discussion papers, “Using Artificial Intelligence and Machine Learning in the Development of Drug and Biological Products,” and “Artificial Intelligence in Drug Manufacturing.”
Recommend0 recommendationsPublished in US National Health Agency Sources